Published in Am J Clin Nutr on September 01, 1979
Inhibition of host cell catalase by Mycoplasma pneumoniae: a possible mechanism for cell injury. Infect Immun (1983) 1.22
Oxidative stress and β-thalassemic erythroid cells behind the molecular defect. Oxid Med Cell Longev (2013) 0.78
Necrotizing myopathy with paracrystalline inclusion bodies in hypervitaminosis E. Acta Neuropathol (1987) 0.75
Is supplementation efficacious in maintaining adequate plasma levels of vitamin a and e for thalassemic patients undergoing hematopoietic stem cell transplantation? A cross-sectional study. Iran J Pediatr (2014) 0.75
Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. Cell (1981) 3.80
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Major glycoprotein of the human erythrocyte membrane: evidence for an amphipathic molecular structure. Arch Biochem Biophys (1973) 2.44
Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol (1978) 2.07
The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions. Ann N Y Acad Sci (1974) 1.99
Adherence of Mycoplasma gallisepticum to human erythrocytes. Infect Immun (1978) 1.98
Receptor-mediated internalization of fluorescent chemotactic peptide by human neutrophils. Science (1979) 1.84
Proliferation and maturation of human erythroid progenitors in liquid culture. Blood (1989) 1.78
Immunological analysis of Mycoplasma membranes. J Bacteriol (1969) 1.66
The effects of protein conformation on the heme symmetry in high spin ferric heme proteins as studied by electron paramagnetic resonance. J Biol Chem (1971) 1.57
Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL. QJM (2008) 1.56
Attachment of mycoplasmas to erythrocytes: a model to study mycoplasma attachment to the epithelium of the host respiratory tract. Isr J Med Sci (1981) 1.56
Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. N Engl J Med (1993) 1.51
Synthesis and turnover of membrane protein and lipid in Mycoplasma laidlawii. Biochim Biophys Acta (1969) 1.50
Ovarian tissue banking in patients with Hodgkin's disease: is it safe? Fertil Steril (1998) 1.46
Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood (1983) 1.41
Activated oxygen and haemolysis. Br J Haematol (1975) 1.41
Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives. J Biol Chem (1971) 1.38
Isolation of binding sites to glycophorin from Mycoplasma pneumoniae membranes. Infect Immun (1980) 1.35
Studies on the major sialoglycoprotein of the human red cell membrane. Isolation and characterization of tryptic glycopeptides. Biochemistry (1973) 1.35
Sialic acid residues mediate Mycoplasma pneumoniae attachment to human and sheep erythrocytes. Infect Immun (1982) 1.31
Cholesterol-phosphatidylcholine dispersions as donors of cholesterol to Mycoplasma membranes. Biochim Biophys Acta (1977) 1.29
Adherence of erythrocytes to Mycoplasma pneumoniae. Infect Immun (1979) 1.29
Multiphasic interactions of Mycoplasma pulmonis with erythrocytes defined by adherence and hemagglutination. Infect Immun (1984) 1.28
Detection of the major adhesin P1 in triton shells of virulent Mycoplasma pneumoniae. Infect Immun (1985) 1.26
Cardiopulmonary assessment in beta-thalassemia major. Chest (1990) 1.26
Oxidative denaturation of red blood cells in thalassemia. Semin Hematol (1990) 1.24
Characterization of the mycoplasma membrane proteins. II. Solubilization and enzymic activities of Acholeplasma laidlawii membrane proteins. Biochim Biophys Acta (1971) 1.23
A subpopulation of cultured human promyelocytic leukemia cells (HL-60) displays the formyl peptide chemotactic receptor. Proc Natl Acad Sci U S A (1980) 1.23
Distinguishing between Mn-containing and Fe-containing superoxide dismutases in crude extracts of cells. Arch Biochem Biophys (1980) 1.22
Inhibition of host cell catalase by Mycoplasma pneumoniae: a possible mechanism for cell injury. Infect Immun (1983) 1.22
Molecular features of the major glycoprotein of the human erythrocyte membrane. Fed Proc (1973) 1.20
Lipid membrane peroxidation in beta-thalassemia major. Blood (1976) 1.18
Denaturation of the normal and abnormal hemoglobin molecule. Semin Hematol (1974) 1.17
Adherence of Mycoplasma gallisepticum to glass. J Gen Microbiol (1979) 1.16
Purification and properties of acetate kinase from Acholeplasma laidlawii. J Bacteriol (1979) 1.14
Detection of Mycoplasma pneumoniae adhesin (P1) in the nonhemadsorbing population of virulent Mycoplasma pneumoniae. Infect Immun (1985) 1.13
Role of haemichromes in the formation of inclusion bodies in haemoglobin H disease. Nature (1969) 1.12
Characterization of the mycoplasma membrane proteins. VI. Composition and disposition of proteins in membranes from aging Mycoplasma hominis cultures. Biochim Biophys Acta (1976) 1.11
Role of superoxide anion in host cell injury induced by mycoplasma pneumoniae infection. A study in normal and trisomy 21 cells. J Clin Invest (1984) 1.10
Characterization of the myoplasma membrane proteins. 3. Gel filtration and immunological characterization of Acholeplasma laidlawii membrane proteins. Biochim Biophys Acta (1972) 1.10
Binding of plant lectins to mycoplasma cells and membranes. J Bacteriol (1976) 1.09
Serum lipoproteins as cholesterol donors to mycoplasma membranes. Biochem Biophys Res Commun (1976) 1.09
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol (1995) 1.09
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood (1996) 1.08
beta 0-Thalassemia complicated by autoimmune hemolytic anemia. Globin synthesis during immunosuppressive therapy. Acta Haematol (1980) 1.06
Isolation of membrane glycoproteins by affinity chromatography in the presence of detergents. Biochim Biophys Acta (1976) 1.06
Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci (1970) 1.05
Divalent cations in native and reaggregated mycoplasma membranes. J Bacteriol (1973) 1.05
The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br J Haematol (1986) 1.05
Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. Isr J Med Sci (1972) 1.05
Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemia. Clin Endocrinol (Oxf) (1978) 1.04
Isolation of a glycoprotein from Mycoplasma pneumoniae membranes. Infect Immun (1977) 1.04
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol (1997) 1.02
A new polymorphism in the human beta-globin gene useful in antenatal diagnosis. J Clin Invest (1981) 1.02
Erythropoietin triggers a burst of GATA-1 in normal human erythroid cells differentiating in tissue culture. Nucleic Acids Res (1993) 1.00
Adherence of mycoplasmas to cells and inert surfaces: phenomena, experimental models and possible mechanisms. Isr J Med Sci (1981) 1.00
Absence of beta mRNA in beta0-thalassemia in Kurdish Jews. Blood (1978) 1.00
Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. Blood (1987) 0.99
Novel treatment options in the severe beta-globin disorders. Br J Haematol (1995) 0.99
The demonstration of ferrihemochrome intermediates in heinz body formation following the reduction of oxyhemoglobin A by acetylphenylhydrazone. Biochim Biophys Acta (1975) 0.99
Toward anti-adhesion therapy for microbial diseases. Trends Microbiol (1996) 0.98
Blood group phenotypes and hemoglobin S. An anthropologic study in two Israeli Arab communities. Acta Haematol (1976) 0.98
Superoxide dismutase in red blood cells: method of assay and enzyme content in normal subjects and in patients with beta-thalassemia (major and intermedia). J Lab Clin Med (1976) 0.98
Mean corpuscular volume of heterozygotes for beta-thalassemia correlates with the severity of mutations. Blood (1992) 0.98
Carbohydrate content and enzymic activites in the membrane of Spiroplasma citri. J Gen Microbiol (1977) 0.97
The two-step liquid culture: a novel procedure for studying maturation of human normal and pathological erythroid precursors. Stem Cells (1993) 0.97
Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy. Proc Natl Acad Sci U S A (1979) 0.96
Juvenile leg ulceration in beta-thalassemia major and intermedia. Plast Reconstr Surg (1982) 0.96
Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol (1993) 0.96
In vitro studies on the mechanism of adherence and pathogenicity of mycoplasmas. Isr J Med Sci (1984) 0.95
Protective effects of the glutathione redox cycle and vitamin E on cultured fibroblasts infected by Mycoplasma pneumoniae. Infect Immun (1986) 0.95
Blood group phenotypes and the origin of sickle cell hemoglobin in Sicilians. Acta Haematol (1978) 0.94
Red cell membrane glycophorin labeling from within the lipid bilayer. Science (1978) 0.94
Influence of cell shape and surface charge on attachment of Mycoplasma pneumoniae to glass surfaces. J Bacteriol (1983) 0.94
Visceral leishmaniasis: a difficult diagnosis and unusual causative agent. J Infect Dis (1991) 0.94
A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol (1999) 0.93
Two mutations in the beta-globin polyadenylylation signal reveal extended transcripts and new RNA polyadenylylation sites. Proc Natl Acad Sci U S A (1992) 0.92
In vivo and in vitro impairment of human and ram sperm nuclear chromatin integrity by sexually transmitted Ureaplasma urealyticum infection. Biol Reprod (2000) 0.92
Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: mechanism of activation of blood coagulation. Am J Hematol (1997) 0.91
Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. J Clin Invest (1989) 0.91
Acetate kinase activity in mycoplasmas. J Bacteriol (1981) 0.91
Nonspecific serum iron in thalassemia: quantitation and chemical reactivity. Am J Hematol (1979) 0.91
Expression of granulocytic functions by leukemic promyelocytic HL-60 cells: differential induction by dimethylsulfoxide and retinoic acid. Cell Differ (1987) 0.90
Homozygous beta0- and beta+ - thalassemia in Kurdish Jews and Arabs. Hemoglobin (1977) 0.90
Adherence of Mycoplasma gallisepticum involves variable surface membrane proteins. Infect Immun (1997) 0.90
In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood (1991) 0.90
Ultrastructural studies in -thalassaemia major. Br J Haematol (1973) 0.89
Characterization of the mycoplasma membrane proteins. I. Reaggregation of solubilized membrane proteins of Acholeplasma laidlawii. Biochim Biophys Acta (1971) 0.89
The interaction of hemoglobin O Arab with Hb S and beta+ thalassemia among Israeli Arabs. Hum Genet (1985) 0.89
Cholesterol transfer from serum lipoproteins to mycoplasma membranes. Biochemistry (1977) 0.89
Formation of hemichromes from oxidized hemoglobin subunits. Ann N Y Acad Sci (1969) 0.89
Panagrellus redivivus and Caenorhabditis elegans: evidence for the absence of sialic acids. Exp Parasitol (1990) 0.88
Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin Endocrinol (Oxf) (1993) 0.88
Self-renewal and commitment to differentiation of human leukemic promyelocytic cells (HL-60). J Cell Physiol (1982) 0.88
Mechanism of desferrioxamine-induced iron excretion in thalassaemia. Br J Haematol (1979) 0.88
Thromboembolic complications in beta thalassemia major. Acta Haematol (1992) 0.87
Scanning electron microscopy of mycoplasmas adhering to erythrocytes. Infect Immun (1980) 0.87
Phagocytosis of nucleated and mature beta thalassaemic red blood cells by mouse macrophages in vitro. Br J Haematol (1979) 0.87